HLB Therapeutics Co Ltd (115450) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	16.06B	22.78B	13.05B	12.56B
Cost of goods sold	16.93B	15.80B	13.76B	13.93B
Cost of revenue	16.93B	15.80B	13.76B	13.93B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.56B	2.86B	2.28B	2.07B
Operating expense	4.56B	2.88B	2.52B	3.36B
Total operating expenses	21.49B	18.68B	16.28B	17.29B
Operating income	-5.43B	4.09B	-3.24B	-4.73B
Other non operating income	98.79M	-15.45M	-72.96K	12.20M
EBT including unusual items	-5.59B	-1.18B	-4.45B	-8.82B
EBT excluding unusual items	-6.62B	146.67M	-4.70B	-8.78B
Income tax expense	-	-1.68B	-	223.63M
Effective tax rate	-	142.88%	-	-2.54%
Other operating expenses	94.74M	-4.70M	62.65M	85.30M
Net income	-5.48B	642.67M	-4.32B	-8.87B
Net profit margin	-34.11%	2.82%	-33.11%	-70.59%
Earnings per share	-	-	-	-
Interest and investment income	152.74M	59.27M	105.82M	71.81M
Interest expense	-327.63M	-353.28M	-487.18M	-514.28M
Net interest expenses	-174.89M	-294.02M	-381.36M	-442.47M
Depreciation and amortization charges	222.85M	235.01M	262.42M	262.85M
EBITDA	-4.97B	4.63B	-2.62B	-4.10B
Gain or loss from assets sale	24.88M	-	-	40.28M

Finance